Abstract Background Invasive pleomorphic lobular carcinoma (PLC) is an aggressive subtype of invasive lobular carcinoma of the breast, which has its own histopathological and biological features. The metastatic patterns for PLC are distinct from those of invasive ductal carcinoma. In addition, pancreatic metastasis from PLC is extremely rare. Case presentation We report a rare case of a 48-year-old woman presenting with clinical gastrointestinal symptoms and pancreatic metastasis of PLC. The pancreatic tumor was composed of pleomorphic tumor cells arranged in the form of solid sheets and nests and as single files, with frequent mitotic figures, nucleolar prominence, high nuclear to cytoplasmic ratio and loss of cohesion. The malignant cells...
Immunohistochemical analysis of E-cadherin has changed the way lobular neoplasia is perceived. It ha...
We report a case of diffuse gastric metastasis from lobular carcinoma of the breast arising in a 65-...
AbstractIntroductionAt time of presentation, fewer than 10% of patients have metastatic breast cance...
Pleomorphic lobular carcinoma (PLC) of the breast is an uncommon variant of invasive lobular carcino...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Background: Invasive lobular carcinoma (ILC) is the second most common histological type of invasive...
We report the case of a 51 year-old female who complained of jaundice and weight loss. At the time o...
Background: Metastasis to the pancreas originating from malignant tumours is a rare event and, in th...
Pleomorphic lobular carcinoma of the breast is associated with aggressive behavior. CASE: Fine needl...
Pleomorphic lobular carcinoma of the breast has been identified as a histological variant of infiltr...
Introduction . We present an unusual case of metastatic lobular breast carcinoma. Typical areas of m...
Invasive lobular carcinomas are the second most common type (5 % to 15%) of invasive breast carcinom...
We report here an extremely rare case of breast signet-ring cell carcinoma (SRCC) initially manifest...
We report here an extremely rare case of breast signet-ring cell carcinoma (SRCC) initially manifest...
ABSTRACT CONTEXT: Pancreatic metastases from primary malignant tumors at other sites are rare, cons...
Immunohistochemical analysis of E-cadherin has changed the way lobular neoplasia is perceived. It ha...
We report a case of diffuse gastric metastasis from lobular carcinoma of the breast arising in a 65-...
AbstractIntroductionAt time of presentation, fewer than 10% of patients have metastatic breast cance...
Pleomorphic lobular carcinoma (PLC) of the breast is an uncommon variant of invasive lobular carcino...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Background: Invasive lobular carcinoma (ILC) is the second most common histological type of invasive...
We report the case of a 51 year-old female who complained of jaundice and weight loss. At the time o...
Background: Metastasis to the pancreas originating from malignant tumours is a rare event and, in th...
Pleomorphic lobular carcinoma of the breast is associated with aggressive behavior. CASE: Fine needl...
Pleomorphic lobular carcinoma of the breast has been identified as a histological variant of infiltr...
Introduction . We present an unusual case of metastatic lobular breast carcinoma. Typical areas of m...
Invasive lobular carcinomas are the second most common type (5 % to 15%) of invasive breast carcinom...
We report here an extremely rare case of breast signet-ring cell carcinoma (SRCC) initially manifest...
We report here an extremely rare case of breast signet-ring cell carcinoma (SRCC) initially manifest...
ABSTRACT CONTEXT: Pancreatic metastases from primary malignant tumors at other sites are rare, cons...
Immunohistochemical analysis of E-cadherin has changed the way lobular neoplasia is perceived. It ha...
We report a case of diffuse gastric metastasis from lobular carcinoma of the breast arising in a 65-...
AbstractIntroductionAt time of presentation, fewer than 10% of patients have metastatic breast cance...